- Home
- Innovation
Innovation
“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
6 impactful ways Johnson & Johnson is helping in the fight against COVID-19
From work on an investigational vaccine candidate to a $50 million commitment in support of healthcare workers on the very front lines of the crisis around the world, learn how the company has taken action to help respond to the pandemic.
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
What it really feels like to have multiple sclerosis
The exact cause of the disease is unknown, but there’s a lot scientists do know about how it impacts nearly every part of the body. Scientists like Tatiana Scherz, M.D., who takes us on a guided journey of how the disease manifests—from your brain down to your toes.
Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that’s tackling the problem of AFib
Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.
Could the answer to preventing hospital-acquired pneumonia be as simple as better oral care? This nurse thinks so.
Some 157,000 patients are diagnosed with the condition each year. But trailblazing nurse Dian Baker has a straightforward yet innovative solution.
An expert explains the latest good—yes, good!—news about lung cancer
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what’s to come in better detecting and preventing it.
By the numbers: 6 ways Johnson & Johnson is helping support coronavirus relief efforts
From a donation of a million masks to help protect vulnerable healthcare workers to committed research on a potential vaccine, the company has activated quickly in several key ways to help address the outbreak.
That’s so presidential! 4 of Johnson & Johnson’s most memorable moments with heads of state
In honor of Presidents’ Day, the company’s chief historian shares some stories of special company connections to former U.S. presidents, including the day one leader awarded Johnson & Johnson with a medal for a century’s worth of innovation.
What you need to know about the coronavirus—and a potential preventive vaccine
The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.